OPTIMIZERx Corp

$12.14
(as of May 30, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for OPTIMIZERx Corp

Stock Price
$12.14
Ticker Symbol
OPRX
Exchange
NASDAQ

Industry Information for OPTIMIZERx Corp

Sector
Healthcare
Industry
Health Information Services

Company Description for OPTIMIZERx Corp

Country
USA
Full Time Employees
128

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.

Fundamentals for OPTIMIZERx Corp

Market Capitalization
$233,778,592
EBITDA
$1,023,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
21.79
Earnings per Share
$-0.81
Earnings per Share Estimate Next Year
Profit Margin
-16.33%
Shares Outstanding
18,495,100
Percent Owned by Insiders
7.23%
Percent Owned by Institutions
66.28%
52-Week High
52-Week Low

Technical Indicators for OPTIMIZERx Corp

50-Day Moving Average
200-Day Moving Average
RSI
62.53
0.89

Analyst Ratings for OPTIMIZERx Corp

Strong Buy
4
Buy
2
Hold
1
Sell
0
Strong Sell
0

News About OPTIMIZERx Corp

May 16, 2025, 7:30 AM EST
WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences: See more.
Apr 23, 2025, 7:30 AM EST
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Monday, May 12, 2025, at 4:30 p.m. See more.
Apr 18, 2025, 4:15 PM EST
WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that, as part of OptimizeRx’s ongoing process to refresh and expand its board of directors (the “Board”), it intends to appoint a new independent director to its Board of Directors during the second half of this year. See more.
Mar 12, 2025, 7:30 AM EST
Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company generated revenue from 48 DAAP deals in 2024, up from 24 in 2023 See more.